CVRx IncNASDAQ:CVRX
- LAST PRICE16.6300
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots13.7000/ 1
- Ask / Lots26.6000/ 2
- Open / Previous Close0.0000 / 16.6300
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | CVRX |
|---|---|---|
| 09:32 ET | 424 | 17.24 |
| 09:36 ET | 100 | 17.26 |
| 09:45 ET | 200 | 17.41 |
| 09:54 ET | 100 | 17.21 |
| 10:03 ET | 100 | 17.035 |
| 10:08 ET | 200 | 17.07 |
| 10:10 ET | 3960 | 16.9 |
| 10:12 ET | 935 | 16.94 |
| 10:15 ET | 500 | 17.04 |
| 10:17 ET | 100 | 17.09 |
| 10:24 ET | 100 | 17.09 |
| 10:26 ET | 600 | 17.005 |
| 10:32 ET | 2177 | 16.81 |
| 10:35 ET | 800 | 16.7 |
| 10:37 ET | 600 | 16.78 |
| 10:53 ET | 1734 | 16.8 |
| 11:08 ET | 482 | 16.73 |
| 11:13 ET | 1908 | 16.82 |
| 11:15 ET | 435 | 16.85 |
| 11:29 ET | 200 | 16.9 |
| 11:38 ET | 700 | 16.87 |
| 12:00 ET | 500 | 16.94 |
| 12:09 ET | 400 | 16.89 |
| 12:12 ET | 400 | 16.85 |
| 12:14 ET | 100 | 16.87 |
| 12:20 ET | 100 | 16.805 |
| 12:21 ET | 100 | 16.84 |
| 12:34 ET | 100 | 16.72 |
| 12:36 ET | 100 | 16.77 |
| 12:43 ET | 200 | 16.7 |
| 12:48 ET | 100 | 16.675 |
| 12:52 ET | 100 | 16.72 |
| 12:54 ET | 100 | 16.7 |
| 12:56 ET | 100 | 16.67 |
| 12:59 ET | 200 | 16.65 |
| 01:01 ET | 500 | 16.645 |
| 01:03 ET | 100 | 16.68 |
| 01:06 ET | 644 | 16.71 |
| 01:08 ET | 1100 | 16.75 |
| 01:12 ET | 100 | 16.805 |
| 01:21 ET | 200 | 16.67 |
| 01:28 ET | 350 | 16.7 |
| 01:30 ET | 260 | 16.6 |
| 01:32 ET | 500 | 16.59 |
| 01:33 ET | 833 | 16.61 |
| 01:35 ET | 400 | 16.74 |
| 01:57 ET | 200 | 16.74 |
| 02:02 ET | 100 | 16.78 |
| 02:18 ET | 400 | 16.59 |
| 02:24 ET | 200 | 16.6 |
| 02:36 ET | 1070 | 16.66 |
| 02:38 ET | 202 | 16.64 |
| 02:40 ET | 100 | 16.6361 |
| 02:54 ET | 200 | 16.51 |
| 02:56 ET | 1691 | 16.53 |
| 02:58 ET | 300 | 16.535 |
| 03:00 ET | 579 | 16.51 |
| 03:02 ET | 1100 | 16.55 |
| 03:03 ET | 300 | 16.5 |
| 03:05 ET | 5900 | 16.5 |
| 03:07 ET | 500 | 16.51 |
| 03:09 ET | 400 | 16.49 |
| 03:12 ET | 800 | 16.505 |
| 03:14 ET | 100 | 16.5 |
| 03:16 ET | 100 | 16.52 |
| 03:18 ET | 200 | 16.5 |
| 03:21 ET | 100 | 16.485 |
| 03:32 ET | 2500 | 16.52 |
| 03:34 ET | 300 | 16.53 |
| 03:38 ET | 400 | 16.61 |
| 03:39 ET | 1595 | 16.64 |
| 03:43 ET | 100 | 16.64 |
| 03:45 ET | 100 | 16.68 |
| 03:48 ET | 100 | 16.67 |
| 03:50 ET | 400 | 16.685 |
| 03:52 ET | 200 | 16.68 |
| 03:54 ET | 700 | 16.665 |
| 03:56 ET | 1400 | 16.645 |
| 03:57 ET | 800 | 16.64 |
| 03:59 ET | 17156 | 16.63 |
Yesterday
CVRx announces availability of additional data supporting long-term benefits of Barostim, from 7:30AM ET on Monday Apr 15, 2024 by Dow Jones
7:30AM ET on Monday Apr 15, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
CVRx Inc | 348.0M | -8.4x | --- |
Pulmonx Corp | 289.9M | -4.7x | --- |
Utah Medical Products Inc | 245.3M | 14.9x | +2.27% |
Sight Sciences Inc | 274.0M | -4.8x | --- |
Surmodics Inc | 376.1M | 67.6x | --- |
Senseonics Holdings Inc | 232.0M | -4.3x | --- |
Company Information
CVRx, Inc. is a commercial-stage medical device company. The Company is focused on developing, manufacturing and commercializing advanced neuromodulation solutions for patients with cardiovascular diseases. The Company's integrated platform technology, Barostim, is designed to leverage the power of the brain and nervous system to address the imbalance of the autonomic nervous system (ANS), which causes heart failure with reduced ejection fraction (HFrEF) and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy (BAT) by sending imperceptible and persistent electrical pulses to baroreceptors located in the wall of the carotid artery to signal the brain to modulate cardiovascular function. Barostim is a minimally invasive neuromodulation device that consists of two implantable components, an implantable pulse generator (IPG) and a stimulation lead, and is programed by a wireless clinician-controlled programmer that communicates with the IPG.
Contact Information
- Headquarters
- 9201 West Broadway Avenue, Suite 650MINNEAPOLIS, MN, United States 55445
- Phone
- 763-416-2850
- Fax
- 763-416-2841
Executives
- President, Chief Executive Officer
- Kevin Hykes
- Chief Financial Officer
- Jared Oasheim
- Senior Vice President - US Sales
- Craig Palmer
- Chief Marketing and Strategy Officer
- Paul Verrastro
- Vice President - Global Clinical Research
- Liz Galle
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $348.0M |
|---|---|
Revenue (TTM) | $39.3M |
Shares Outstanding | 20.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-1.99 |
Book Value | $3.64 |
P/E Ratio | -8.4x |
Price/Sales (TTM) | 8.9 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -109.69% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
